Risks

Net debt to EBITDA above 30x and interest coverage below 1x leave ACR far more exposed to refinancing and spread widening than most direct peers, constraining growth flexibility.

Current and quick ratios at zero indicate minimal liquidity buffer, so any claims volatility or reserve timing mismatch could pressure operations more than better-capitalized peers.

Debt-to-equity above 4x increases sensitivity to asset-value or funding shocks, making ACR’s balance-sheet resilience weaker than insurers with lower leverage and stronger capital cushions.

Days sales outstanding near 66 days versus peers’ typically faster premium collection cycles can delay cash realization, amplifying working-capital strain when underwriting conditions soften.

Opportunities

Negative cash conversion cycle of roughly 15 days supports cash generation efficiency versus peers with longer working-capital cycles, improving liquidity despite leverage.

Days of payables outstanding above 80 days can preserve operating cash relative to peers, helping ACR fund claims and expenses more efficiently in a tight-rate environment.

If underwriting discipline holds, ACR’s cash-efficient operating profile can translate into faster deleveraging than peers with weaker working-capital conversion, improving positioning over 1–5 years.

Overall Score

ACR’s cash-efficient operating cycle is a meaningful offset, but extreme leverage, weak coverage, and thin liquidity leave its forward positioning materially below better-capitalized peers.